Ethicon designs sutures for the needs of surgery - overseeing development from monomer, to polymer, to fiber, to the thread our customers use and trust every day.WATCH AND LEARN MORE IN THIS EPISODE, ‘BEYOND THREAD’ >
This acquisition is consistent with the Johnson & Johnson Medical Devices’ strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology.READ THE FULL PRESS RELEASE >
Vizient recognizes the EVARREST® Fibrin Sealant Patch and the EVICEL™ Airless Spray Accessory as solutions that benefit the health care industry.View EVARREST important safety information > View EVICEL important safety information > READ MORE >
The first and only purely ultrasonic energy device with a 7mm vessel sealing indication, delivering unmatched precision, multifunctionality, and now stronger large vessel sealing†.Pure ultrasonic energy >
Shaping the future of surgery
At Ethicon, we are bringing people together from around the world to create innovative solutions that are advancing surgery and having life-changing impacts in health care.
- * In bench-top studies using 5-7 mm porcine carotids that compared median burst pressures for HARMONIC ACE®+7 (1716.5 mmHg) vs. Thunderbeat™ (1528.3 mmHg) (p=0.0226); HARMONIC ACE®+7 (1419.5 mmHg) vs. LigaSure™ Advance (670.5 mmHg) (p< 0.001); and HARMONIC ACE®+7 (1419.5 mmHg) vs. LigaSure™ 5 mm Blunt Tip (591.0 mmHg) (p<0.001). Data on file. Ethicon Endo-Surgery, Inc. (PRC064872B, PRC064872B).
- † Internal market analysis as of 1/31/2014. Data on file, Ethicon Endo-Surgery (SCN034259).